Intelligent Living, Inc. (OTCMKTS:ILIV) Doubles Again on Improved Market Mood
Intelligent Living, Inc. (OTCMKTS:ILIV) awakened to stronger gains after a few days of setbacks and thinner trading. ILIV added more than 116% on Wednesday, reaching $0.0078, on dollar volumes of $1.91 million, in what looks like bargain-seeking. ILIV, at its extremely low levels, is not showing anything unusual, as doubling the price is easily achieved from those accessible positions. 
ILIV drifted off for a few days when the PR and promotions slowed down, but the setback was not that catastrophic as with other tickers at this range. The latest mention for ILIV came on January 6th, from OTC Stock Center, and a press release on the next day boosted the ticker further. Otherwise, ILIV is automatically in demand as a novel cannabis stock. ILIV is also lifted by the tide on generally good days.
ILIV has always been on the sidelines, as other cannabis companies took front stage. Still, this selection boasts a bit more solid business, as ILIV has a history of health and wellness products. The unaudited reports for 2013 show:
- $40,312 yearly revenues
- $3.71 million net income for the year until June 2013
- Zero revenues for the next quarter
- $260,986 net loss for the quarter ended September 30th 2013
- $50,604 cash
Clearly, there is a disparity in reporting, as the company put extraordinary items in its reports to seemingly boost earnings.
Still, investors’ forums see ILIV as potentially going upward to a few pennies- a development not unheard of in the past days, as more and more double-zero selections rose once they attached themselves in any way to the marijuana boom.
Perhaps the most prominent example is Easton Pharmaceuticals, Inc. (OTCMKTS:EAPH), a company that knows when to ride a trend. Unfortunately, the stem cell madness left EAPH a bit cold, so at the start of 2014 there were at least promises that medical cannabis would be added to the company’s research. This shot EAPH upward from a low of $0.0025 to nearly $0.08, as now the price backtracked a bit toward $0.05. EAPH has enough red flags to justify the low price, but also has enough forward-looking drive to be still interesting to investors.
The same model and a similar run upward applies to Creative Edge Nutrition, Inc. (OTCMKTS:FITX), a producer of food supplements that now plans to develop a medical cannabis product. FITX also started at a quarter of a penny, and moved toward the 10-cent levels, but for now hangs around $0.008.
If you like ILIV for the potential to repeat any of the stories, keep in mind that while pot stocks remain active, there is no guarantee an individual ticker would lock in the tremendous gains. Avoid over-investing, as deep cuts happen more often to double-zero selections.
